ESR2 and melanoma: In order to investigate the potential ERβ antitumor role in melanoma upon receptor specific hormonal activation, we evaluated the effects of the specific ERβ agonist LY500307 on cell proliferation/viability of Me1402/R, A375M and Me665/1 melanoma cell lines (Fig. S1).